Abnormal growth: Definition, pathogenesis, and practical assessment

Growth Disorders, Second Edition

Volumn , Issue , 2007, Pages 185-207

  Donaldson, Malcolm D C ^a   Paterson, Wendy ^a  

^a ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876230485     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (65)

1. Tanner JM, Kelnar CJH. Physical growth, development and puberty. In: Campbell AGM, McIntosh N, eds. Forfar and Arneil’s Textbook of Paediatrics, 4th edn. Edinburgh: Churchill Livingstone, 1992: 389–445.
2. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity and weight velocity: British children 1965, Part I. Arch Dis Child 1966; 41: 454–71.
3. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976; 51: 170–9.
4. Hall JG, Froster-Iskenius UG, Allanson JE. Handbook of Normal Physical Measurements. Oxford: Oxford University Press, 1989.
5. Tanner JM, Whitehouse RH. Revised standards for triceps and subscapular skinfolds in British children. Arch Dis Child 1975; 50: 142–5.
6. Laman TG. Advances in body composition assessment. In: Current Issues in Exercise Science Series, Monograph 3. Champaign, Illinois: Human Kinetics Publishers, 1992.
7. Goran MI, Driscoll P, Johnson R, et al. Cross-calibration of body-composition techniques against dual-energy X-ray absorptiometry in young children. Am J Clin Nutr 1996; 63: 299–305.
8. Bachrach LK. Dual energy X-ray absorptiometry (DEXA) measurements of bone density and body composition: promise and pitfalls. J Pediatr Endocrinol Metab 2000; 13(Suppl 2): 983–8.
9. Sanchez MM, Gilsanz V. Pediatric DXA bone measurements. Pediatr Endocrinol Rev 2005; 2(Suppl 3): 337–41.
10. Shalet SM, Gibson BE, Swindell R, Pearson D. Effect of spinal irradiation on growth. Arch Dis Child 1987; 62: 461–4.
11. Cizmecioglu F, Doherty A, Paterson WF, et al. Measured versus reported parental height. Arch Dis Child 2005; 90: 941–2.
12. Tanner JM, Goldstein H, Whitehouse RH. Standards for children’s height at ages 2–9 years allowing for height of parents. Arch Dis Child 1970; 45: 755–62.
13. Tanner JM, Whitehouse RH, Takaishi M. Standards for birth to maturity for height, weight, height velocity and weight velocity: British children, 1965, Part II. Arch Dis Child 1966; 45: 613–35.
14. DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight are known. Arch Intern Med 1916; 17: 863–71.
15. Voss L, Walker J, Lunt H, et al. The Wessex Growth Study: First Report. Acta Paediatr Scand Suppl 1989; 349: 65–72.
16. Smith DW, Truog W, Rogers JE, et al. Shifting linear growth during infancy: illustration of genetic factors in growth from fetal life through infancy. J Pediatr 1976; 89: 225–30.
17. Tanner JM. Growth at Adolescence, 2nd edn. Oxford: Blackwell Scientific, 1962.
18. Tanner JM, Whitehouse RH, Cameron N, et al. Assessment of Skeletal Maturity and Prediction of Adult Height (TW2 Method), 2nd edn. London: Academic Press, 1983.
19. Tanner JM, Healy MJR., Goldstein H, Cameron N. Assessment of Skeletal Maturity and Prediction of Adult Height (TW3 Method), 3rd edn. London: WB Saunders, 2001.
20. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist, 2nd edn. Stanford, California: Stanford University Press, 1959.
21. Bayley N, Pinneau SR. Tables for predicting adult height from skeletal age: revised for use with the Greulich–Pyle hand standards J Pediatr 1952; 40: 423–41.(Published errata appear in J Pediatr 1952; 41: 371.) 22
22. Kelly BP, Paterson WF, Donaldson MDC. Final height outcome and value of height prediction in boys with constitutional delay in growth and adolescence treated with intramuscular testosterone 125 mg per month for 3 months. Clin Endocrinol 2003; 58: 267–72.
23. Griffin IJ, Cole TJ, Duncan KA, et al. Pelvic ultrasound measurements in normal girls. Acta Paediatr Scand 1995; 84: 536–43.
24. Freeman JV, Cole TJ, Chinn S, et al. Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 1995; 73: 17–24.
25. Roche AF, Davila GH. Late adolescent growth in stature. Pediatrics 1972; 50: 872–80.
26. Lindgren G. Growth of schoolchildren with early, average and late ages of peak height velocity. Ann Hum Biol 1978; 5: 253–67.
27. Tanner JM, Davies PSW. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr 1985; 107: 317–29.
28. Buckler JMH. A Longitudinal Study of Adolescent Growth. London: Springer-Verlag, 1990.
29. Cole TJ, Freeman JV, Preece MA. Body mass index reference curves for the UK, 1990. Arch Dis Child 1995; 73: 25–9.
30. Tse WY, Hindmarsh PC, Brook CGD. The infancy– childhood–puberty model of growth: clinical aspects. Acta Paediatr Scand Suppl 1989; 356: 38–43.
31. Nobels F, Dewailly D. Puberty and polycystic ovarian syndrome. The insulin/insulin-like growth factor hypothesis. Fertil Steril 1992; 58: 655–63.
32. Legro RS. Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome. J Pediatr Endocrinol Metab 2002; 15(Suppl 5): 1367–78.
33. Stanhope R, Brook CGD. Disorders of puberty. In: Brook CGD, ed. Clinical Paediatric Endocrinology, 2nd edn. Oxford: Blackwell Scientific, 1989.
34. Hulse JA. Referral criteria for growth screening. J Med Screen 1995 2: 168–70.
35. Law CM. The disability of short stature. Arch Dis Child 1987; 62: 855–9.
36. Sandberg DE, Voss LD. The psychosocial consequences of short stature: a review of the evidence. Best Pract Res Clin Endocrinol Metab 2002; 16: 449–63.
37. Erling A. Why do some children of short stature develop psychologically well while others have problems? Eur J Endocrinol 2004; 151(Suppl 1): 535–9.
38. Balfour-Lynn L. Growth and childhood asthma. Arch Dis Child 1986; 61: 1049–55.
39. Jones KL. Smith’s Recognizable Patterns of Human Malformation, 6th edn. Philadelphia: WB Saunders Company, 2005.
40. North KN. Neurofibromatosis type 1: review of the first 200 patients in an Australian clinic. J Child Neurol 1993; 8: 395–402.
41. Skuse D, Albanese A, Stanhope R, et al. A new stressrelated syndrome of growth failure and hyperphagia in children, associated with reversibility of growth hormone insufficiency. Lancet 1996; 348: 353–8.
42. Findlay CA, MacDonald JF, Wallace AM, et al. Childhood Cushing’s syndrome, betamethasone nose drops and repeat prescriptions. BMJ 1998; 317: 739–40.
43. Shaw NJ, Fraser NC, Weller PH. Asthma treatment and growth. Arch Dis Child 1997; 4: 284–6.
44. DeVile, CJ, Grant DB, Hayward RD, Stanhope R. Growth and endocrine sequelae of craniopharyngioma. Arch Dis Child 1996; 75: 108–14.
45. Price DA, Johnston DI, Betts PR, et al. Biosynthetic human growth hormone in the UK: an audit of current practice. Arch Dis Child 1994; 71: 266–71.
46. Kant SG, Wit JM, Breuning MH. Genetic analysis of short stature. Horm Res 2003; 60: 157–65.
47. Rosenfeld RG, Hwa V. Toward a molecular basis for idiopathic short stature [Editorial]. J Clin Endocrinol Metab 2004; 89: 1066–7.
48. Rappold GA, Fukami M, Niesler B, et al. Deletions of the homeobox gene SHOX (Short Stature Homeobox) are an important cause of growth failure in children with short stature. J Clin Endocrinol Metab 2002; 87: 1402–6.
49. Binder G, Ranke MB, Martin DD. Auxology is a valuable instrument for the clinical diagnosis of SHOX haploinsufficiency in school-age children with unexplained short stature. J Clin Endocrinol Metab 2003; 88: 4891–6.
50. Attie KM, Carlsson LMS, Rundle AC, Sherman BM. Evidence for partial growth hormone insensitivity among patients with idiopathic short stature. J Pediatr 1995; 127: 244–50.
51. Buckway CK, Guevara-Aguirre J, Pratt KL, et al. The IGF-I generation test revisited: a marker of GH sensitivity. J Clin Endocrinol Metab 2001; 86: 5176–83.
52. Woods KA, Dastot F, Preece MA, et al. Phenotype: genotype relationships in growth hormone insensitivity syndrome. J Clin Endocrinol Metab 1997; 82: 3529–35.
53. Lewis MD, Horan M, Millar DS, et al. A novel dysfunctional growth hormone variant (Ile179Met) exhibits a decreased ability to activate the extracellular signal-regulated kinase pathway. J Clin Endocrinol Metab 2004; 89: 1068–75.
54. Takahashi Y, Kaji H, Okimura Y, et al. Short stature caused by a mutant growth hormone. New Engl J Med 1996; 334: 432–6.
55. Woods KA, Camacho-Hubner C, Savage MO, Clark AJL. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. New Engl J Med 1996; 335: 1342–9.
56. Kofoed EM, Hwa V, Little B, et al. Growth hormone insensitivity associated with a STATb mutation. New Engl J Med 2003; 349: 1139–47.
57. Buckler JMH, Willgerodt H, Keller E. Growth in thyrotoxicosis. Arch Dis Child 1986; 61: 464–71.
58. Clark AJL, Cammas FM, Watt A, et al. Familial glucocorticoid deficiency: One syndrome, but more than one gene. J Mol Med 1997; 75: 394–9.
59. El Kholy M, Job JC, Chaussain JL. Growth of adolescents with anorexia nervosa. Arch Françaises Pediatr 1986; 43: 35–40.
60. Ranke MB, Saenger P. Turner’s syndrome. Lancet 2001; 358: 309–14.
61. Fuerxer F, Carlier R, Iffenecker C, et al. Magnetic resonance imaging of the olfactory sulci in Kallmann syndrome. J Neuroradiol 1996; 23: 223–30.
62. Rosenthal IM, Refetoff S, Rich B, et al. Response to challenge with gonadotrophin-releasing hormone agonist in a mother and her two sons with a constitutively activating mutation of the luteinizing hormone receptor – a clinical research center study. J Clin Endocrinol Metab 1996; 81: 3802–6.
63. Forest MG. Adrenal puberty or adrenarche. Andrologie 1997; 7: 165–86.
64. Stanhope R, Brook CGD. Thelarche variant: a new syndrome of precocious sexual maturation? Acta Endocrinol 1990; 123: 481–6.
65. Foster CM. Endocrine manifestations of McCune–Albright syndrome. Endocrinologist 1993; 3: 359–64.